Open Access

Lipidomics to discover new biomarkers for cardiovascular risk

Congress Session

About the speaker

Doctor Reijo Laaksonen

Tampere University, Tampere (Finland)
2 presentations
0 follower

3 more presentations in this session

Metabolomic profiling in cardiac hypertrophy and failure.

Speaker: Associate Professor C. Perrino (Naples, IT)

Thumbnail

Impact and role of proteomics in cardiovascular disease

Speaker: Professor M. Mayr (London, GB)

Thumbnail

Extra cellular vesicles as biomarkers and novel therapeutic targets.

Speaker: Professor J. Sluijter (Utrecht, NL)

Thumbnail

Access the full session

Dissecting the secretome in the "omics" era

Speakers: Doctor R. Laaksonen, Associate Professor C. Perrino, Professor M. Mayr, Professor J. Sluijter
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

Related content

Open Access

Integrating EPA based therapy in the management of residual risk.

29 August 2021

Open Access

How the new guidance will impact the treatment of elderly atrial fibrillation patients in clinical practice.

28 August 2021

Open Access

What is new in the 2021 EHRA Practical Guide on the use of NOACs in patients with atrial fibrillation.

28 August 2021

This platform is supported by

logo Novo Nordisk